Paradox between the responses of Escherichia coli K1 to ampicillin and chloramphenicol in vitro and in vivo.
about
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.Prevention and therapy of experimental Escherichia coli infection with monoclonal antibody.In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenesEfficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
P2860
Paradox between the responses of Escherichia coli K1 to ampicillin and chloramphenicol in vitro and in vivo.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Paradox between the responses ...... phenicol in vitro and in vivo.
@ast
Paradox between the responses ...... phenicol in vitro and in vivo.
@en
type
label
Paradox between the responses ...... phenicol in vitro and in vivo.
@ast
Paradox between the responses ...... phenicol in vitro and in vivo.
@en
prefLabel
Paradox between the responses ...... phenicol in vitro and in vivo.
@ast
Paradox between the responses ...... phenicol in vitro and in vivo.
@en
P2093
P2860
P356
P1476
Paradox between the responses ...... phenicol in vitro and in vivo.
@en
P2093
P2860
P304
P356
10.1128/AAC.26.5.689
P407
P577
1984-11-01T00:00:00Z